宫东风英语教学团队编写 高等教育出版社版权所有Unit 1 前言：再读一次大学上大学解放 混大学迟早要还的80后新生赵俊：再读一次大学今年27岁，赵俊再一次迈入了大学校园，成为华东交通大学的一名大一新生，和其他新生不一样的是，他已经拥有了一张某名牌大学的本科毕业证书。上了大学就等于解放了吗7年前，赵俊以优异的成绩考取了国内某名牌大学。大学里宽松的环境，让赵俊有了“上大学就等于解放了”的错觉。赵俊说，那个时候的他自控能力相对较弱，遇到不会做的题目就搁置放弃，不会做的题目越积越多，本已不高的学习兴趣更是被网吧、酒场消磨殆尽。在网吧通宵上网，两三天不回寝室在网络中迷失的赵俊成绩日渐下滑，不少课程相继亮起了红灯。但他依旧选择了逃避，继续用网络麻醉自己。“其实我自己对这种生活也感到很痛苦！”赵俊说，大学期间辅导员和他关系很好，但无论老师如何努力，都没能让他摆脱这种状况。“直到现在，他都是我特敬重的老师。”终于“挣扎”到2009年，赵俊领到了自己的本科毕业证书。拿着一纸文凭，他却始终感觉自己还没有毕业。“大学4年都在混日子，得过且过，甚至都不知道自己的长处和短处是什么！这算毕业嘛？”他嘲笑着自己。混大学给自己带来太多遗憾毕业后，赵俊拥有了一份“还算不错”的工作。工作中，赵俊发现自己的知识面非常狭窄，这让他时常感到“很自卑”。“4年的大学过得太颓废，留下了太多的遗憾。这种感觉在工作期间变得越发强烈。”赵俊坦言，找一份工作对他而言并不是什么问题，但4年大学生活的两手空空，是他始终放不下的一个心结。“我的大学不该就这么度过，我的人生不能这样抱着遗憾走下去。”就这样，赵俊心中萌生了再次考大学的念头。为了补习高中知识，他在工作之余兼职做了一份家教，在教学的同时找回学习的感觉。两年后，经过“深思熟虑”的他下定决心放弃工作，来到某中学跟着一群90后全身心地投入到复习备考中。不出他所料，这个决定遭到了朋友，尤其是父母的强烈反对。“那个时候跟家人闹得很僵，我最好的朋友也说我是精神病。”赵俊的朋友中有的已为人父，而他却要再读一次大学，这在熟识他的人眼中，无疑是一件匪夷所思的事情。为了让儿子“过上正常人的生活”，赵俊的父母也下了很多工夫，“光相亲就安排了10多次”。赵俊笑着说，其中也不乏让他心动的女生，但都被他一一谢绝了。补习的一年，赵俊坚持每天早晨6点钟起床“吼英语”，学习到很晚才休息。“我必须给自己的过去一个交代！”靠着这股倔劲儿，2012年7月，他如愿收到了来自华东交通大学的录取通知书。这一次，一定要真正读一回大学得知儿子再次考上了大学，赵俊的父母也被他的执著所感动，态度渐渐转变，开始支持他在校安心学习，朋友们也相继送来了祝福。“上一次的大学，不能算作毕业。只有自己努力了，流点汗、流点血，有所收获才算毕业。”拿到录取通知书的赵俊，兴奋地提前5天就赶到学校报到。抵达学校的第二天，他就早早起床，“吼”了大半天的英语。“我感到，现在才是读书的真正开始！”两年的工作经历让赵俊清楚地认识到学习的重要性。取到崭新课本的当晚，他就只身一人来到自习室预习。“以前还真没发现上自习也可以这么快乐，让人心安，每天都有收获和进步的感觉很好。”赵俊笑着说。“如果他不说自己是1985年生的，我们还以为他也是90后呢。”在寝室里，赵俊和室友相处得和谐愉快，丝毫没有代沟。看着身边比自己小近10岁的室友，赵俊感慨地说，一路走到现在，真的很不容易。“为了这一步，我放弃了太多。但我更是幸运的！”赵俊说，这一次，他一定会好好珍惜机会，给自己和父母一个交代，“像个男人一样去面对，不再选择逃避生活，过真正的大学生活。”Unknowscomefromknows, tobetheone, finallytobethere!（未知来自已知，做真正的自己！）这是赵俊的QQ签名，也是他4年努力的方向。大学4年不能挂科，获得二等以上奖学金，考取研究生，大学期间创业赚钱，争取出国赵俊不仅为即将展开的大学学业做了详细的规划，还计划在4年里阅读大量的书籍，并多参加一些课外活动，开阔视野、培养能力、提升涵养。“大学，可不仅仅是专业的学习。”“过去的经历是一笔财富。”赵俊说，长大付出的代价让他明白了自己想要什么、应该怎么做，而现在的他，也正以乐观的心态，积极迎接新的挑战。来源：中国青年报2宫东风英语教学团队编写 高等教育出版社版权所有Unit 2 Reading得阅读者得天下In 2010, a federal judge shook Americas biotech industry to its core. Companies had won patents for isolated DNA for decades by 2005 some 20% of human genes were patented. But in March 2010 a judge ruled that genes were unpatentable. Executives were violently agitated. The Biotechnology Industry Organisation (BIO), a trade group, assured members that this was just a “preliminary step” in a longer battle.On July 29th they were relieved, at least temporarily. A federal appeals court overturned the prior decision, ruling that Myriad Genetics could indeed hold patents to two genes that help forecast a womans risk of breast cancer. The chief executive of Myriad, a company in Utah, said the ruling was a blessing to firms and patients alike.But as companies continue their attempts at personalised medicine, the courts will remain rather busy. The Myriad case itself is probably not over. Critics make three main arguments against gene patents: a gene is a product of nature, so it may not be patented; gene patents suppress innovation rather than reward it; and patents monopolies restrict access to genetic tests such as Myriads. A growing number seem to agree. Last year a federal task-force urged reform for patents related to genetic tests. In October the Department of Justice filed a brief in the Myriad case, arguing that an isolated DNA molecule “is no less a product of naturethan are cotton fibres that have been separated from cotton seeds.”Despite the appeals courts decision, big questions remain unanswered. For example, it is unclear whether the sequencing of a whole genome violates the patents of individual genes within it. The case may yet reach the Supreme Court.As the industry advances, however, other suits may have an even greater impact. Companies are unlikely to file many more patents for human DNA molecules most are already patented or in the public domain. Firms are now studying how genes interact, looking for correlations that might be used to determine the causes of disease or predict a drugs efficacy. Companies are eager to win patents for “connecting the dots,” explains Hans Sauer, a lawyer for the BIO.Their success may be determined by a suit related to this issue, brought by the Mayo Clinic, which the Supreme Court will hear in its next term. The BIO recently held a convention which included sessions to coach lawyers on the shifting landscape for patents. Each meeting was packed.31. It can be learned from Paragraph 1 that the biotech companies would like _.A genes to be patentableB the BIO to issue a warningC their executives to be activeD judges to rule out gene patenting32. Those who are against gene patents believe that _.A genetic tests are not reliableB only man-made products are patentableC patents on genes depend much on innovationD courts should restrict access to genetic tests33. According to Hans Sauer, companies are eager to win patents for _.A discovering gene interactions